StopDownOpen the app

Funding · Healthcare & Life Sciences

CureMeAbroad raises $600k pre-seed from angels

By ·

Date
Company
CureMeAbroad
What it does
AI medical tourism platform
Kind
Funding
Amount
$600,000
Stage
pre-seed
Based in
Pune
Founded
June 2025
Sector
Healthcare & Life Sciences

What they do

CureMeAbroad is an AI-powered platform connecting international patients with hospitals and surgeons across multiple countries

What happened

The Pune-based startup secured $600,000 in pre-seed funding led by a group of angel investors including Dr Roman Saini

Why it matters

The company plans to use the funds for deeper tech investments and growth acceleration in GCC, UK, and Africa corridors

The details

  • CureMeAbroad has closed a $600,000 pre-seed funding round.
  • The investment was led by an angel investors group.
  • Notable investors include Dr Roman Saini, co-founder of Unacademy.
  • Himanshu Ratnoo, former CEO of Cars24 India, also participated.
  • Kunal Gupta, co-founder and CEO of EMotorad, invested in the round.
  • Devaiah Bopanna, co-founder of Moonshot, joined as an investor.
  • Vikrant Potnis, founder of IAVC and FundEnable, backed the startup.
  • AIRA Buildon participated as another key investor in this round.

The bigger picture

  • The global medical tourism market is expected to hit $174 billion by 2035.
  • Around 14 million people travel across borders for medical care each year.
  • The sector currently has problems like unclear pricing and unverified listings.
  • CureMeAbroad uses AI to fix these gaps in the medical tourism industry.
  • The startup is focusing on growth in the GCC, UK, and Africa regions.

About the business

  • The platform uses AI to match patients with suitable hospitals globally.
  • It connects international patients with verified surgeons and destinations directly.
  • The system features an AI cost estimator trained on procedure records.
  • Clinical matching models help find the best care options for users.
  • A multilingual patient intelligence layer supports diverse international user bases.
  • The platform is HIPAA certified to ensure data privacy and security.
  • It maintains a directory of over 6,000 hospitals worldwide.
  • CureMeAbroad covers 47 countries and 45 medical specialties.
  • There are 380+ accredited partner hospitals in its network.
  • Partner locations include Mexico, Turkey, Thailand, India, and Georgia.
  • The startup posted an annual run rate of $3.5 million in its first two quarters.

What happens next

  • The company will invest deeper in tech like cost estimators and clinical matching.
  • It plans to build a core team for product and clinical operations.
  • Growth acceleration is targeted for GCC, UK, and Africa corridors.
  • Active conversations are ongoing for a seed round with institutional investors.

The deal

Type
pre-seed

Investors

  • angel investors group (lead)
  • Dr Roman Saini (investor) — Unacademy co-founder and AIIMS-trained physician.
  • Himanshu Ratnoo (investor) — Former CEO of Cars24 India.
  • Kunal Gupta (investor) — Co-founder and CEO of EMotorad.
  • Devaiah Bopanna (investor) — Co-founder of Moonshot.
  • Vikrant Potnis (investor) — Founder of IAVC and FundEnable.
  • AIRA Buildon (investor)

Founders

  • Aditya Oza, CEO, Co-founder
  • Mikhail Bohra, Co-founder

About CureMeAbroad

Product
Discovery platform with AI cost estimator and multilingual patient intelligence layer
Customers
International patients seeking medical treatment abroad
How it makes money
Marketplace connecting patients to hospitals and surgical providers
What sets it apart
HIPAA-certified platform with proprietary AI trained on 634+ procedure records and directory of 6000+ hospitals across 47 countries

Other articles talking about it

Read it as a card in the app

Same day

All startup news on 21 April 2026 →